Market Place
Sourcing Support
Pfizer cranks up revenue outlook amid Paxlovid sales bump
29 Oct 2024 //
FIERCE PHARMA
Pfizer’s Paxlovid Ineffective Against Long COVID Using 15-Day Regimen: Study
10 Jun 2024 //
BIOSPACE
Pfizer`s Paxlovid fails as 15-day treatment for long COVID, study finds
08 Jun 2024 //
REUTERS
FDA blesses Pfizer with priority review voucher for Paxlovid nod
25 May 2024 //
FIERCE PHARMA
Japan`s Shionogi says COVID treatment did not meet endpoint in late-stage trial
13 May 2024 //
REUTERS
Ex-Pfizer employee convicted of insider trading on COVID drug trial
19 Jan 2024 //
REUTERS
Millions of Paxlovid doses are headed for the bin in Europe
03 Jan 2024 //
FIERCE PHARMA
Pfizer sets Paxlovid price at $1,390 for five-day course
18 Oct 2023 //
ENDPTS
Pfizer slashes revenue forecast on lower COVID sales, will cut costs
14 Oct 2023 //
REUTERS
About 250,000 courses of COVID pill Paxlovid being administered per week
26 Sep 2023 //
REUTERS
US NIH launches long-COVID trials of Pfizer`s Paxlovid, other therapies
31 Jul 2023 //
REUTERS
Pfizer’s COVID-19 oral anti-viral available to more Australians Pharma Benefits
02 Jul 2023 //
NATION ALTRIBUNE
SEC charges former Pfizer employee with insider trading
30 Jun 2023 //
FIERCE PHARMA
Former Pfizer employee charged with insider trading unreleased Covid pill data
29 Jun 2023 //
CNBC
Pfizer`s Paxlovid (nirmatrelvir, ritonavir) Approved In Europe
27 Jun 2023 //
EMA
US FDA approves first oral anti-viral for treatment of COVID-19 in adults
27 May 2023 //
BIOSPECTRUM ASIA
Pfizer`s COVID antiviral Paxlovid gains full US approval
26 May 2023 //
REUTERS
Pfizer`s Paxlovid pulls off a surprise with $4.1B in sales in Q1
03 May 2023 //
FIERCE PHARMA
Pfizer, Merck trim prices in China for Paxlovid, molnupiravir
04 Apr 2023 //
REUTERS
New Yale study evaluates PAXLOVID`s use in Long COVID recovery
21 Mar 2023 //
PR NEWSWIRE
US FDA advisers vote in favor of full approval for Pfizer`s COVID pill Paxlovid
17 Mar 2023 //
REUTERS
Pfizer to replace migraine drug packaging over child safety concerns
16 Mar 2023 //
REUTERS
Data shows Pfizer’s Covid treatment Paxlovid is effective in high-risk adults
15 Mar 2023 //
CNBC
Pfizer`s Paxlovid gets March FDA advisory meeting to discuss full approval
24 Feb 2023 //
ENDPTS
Trio of COVID-19 treatments receive NICE nod
21 Feb 2023 //
PHARMATIMES
Pfizer launches new branded Paxlovid ad for COVID
13 Feb 2023 //
FIERCE PHARMA
FDA axes requirement for positive Covid test before Paxlovid use
01 Feb 2023 //
ENDPTS
With big discounts, 100+ drugs win national coverage in China
18 Jan 2023 //
FIERCE PHARMA
Medscape Survey Finds Reasons Paxlovid Is Underprescribed For Those 65 And Older
12 Jan 2023 //
PR NEWSWIRE
Junshi Biosciences Announces NEJM Publication of Results of Ph3 Study of VV116
29 Dec 2022 //
GLOBENEWSWIRE
India-based Hetero`s Paxlovid generic gets WHO backing
28 Dec 2022 //
REUTERS
Hetero’s ‘NIRMACOM’ gets WHO Prequalification for COVID-19 treatment
26 Dec 2022 //
EXPRESSPHARMA
Drug price group slashes suggested price of Pfizer COVID treatment by 80%
21 Dec 2022 //
REUTERS
US set to pay nearly $2B for Pfizer`s Covid-19 treatment Paxlovid in 2023
15 Dec 2022 //
ENDPTS
Lawmakers press Pfizer on fair commercial price for Comirnaty
14 Dec 2022 //
FIERCEPHARMA
Pfizer says it is working to improve supply of COVID drug Paxlovid in China
13 Dec 2022 //
REUTERS
U.S. to pay Pfizer nearly $2 bln for more Paxlovid courses in 2023
13 Dec 2022 //
REUTERS
China NMPA grants IND clearance for trial of Ascletis’ Covid-19 drug
08 Dec 2022 //
CLINICALTRIALSARENA
Pfizer`s hunt for Paxlovid sibling leads to low-profile biotech
06 Dec 2022 //
FIERCEBIOTECH
Could Paxlovid treat long Covid? Major new study aims to find out
25 Nov 2022 //
NBCNEWS
Pfizer Europe`s Paxlovid (nirmatrelvir) Receives Approval in the Europe
23 Nov 2022 //
EMA
Pfizer`s Paxlovid access questioned ahead of WTO patent talks
22 Nov 2022 //
FIERCEPHARMA
NICE recommends Pfizer’s Paxlovid on NHS
17 Nov 2022 //
PHARMATIMES
Covid-19 rebound may be more common in people who take Paxlovid, early study
16 Nov 2022 //
EDITION
U.S. CDC director experiences COVID rebound after taking Pfizer`s Paxlovid
31 Oct 2022 //
REUTERS
NIH to study Pfizer`s Paxlovid in long Covid demand infections continue to fall
28 Oct 2022 //
ENDPTS
Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir
14 Oct 2022 //
JACC
Pfizer to deliver up to six million courses of Paxlovid to Global Fund
23 Sep 2022 //
PHARMACEUTICAL-TECHNOLOGY
Paxlovid Significantly Reduces COVID-19 Hospitalizations and Deaths
22 Sep 2022 //
PRNEWSWIRE
Zenara Pharma Launches Generic Of Paxlovid For COVID-19 In India
09 Sep 2022 //
OUTLOOKINDIA
Study: Pfizer COVID pill showed no benefit in younger adults
25 Aug 2022 //
HEALTH ET
Pfizer`s Paxlovid only helped seniors avoid hospitalization and death: NEJM
24 Aug 2022 //
ENDPTS
Pfizer tabs controversial Chinese firm Huahai to make Paxlovid
24 Aug 2022 //
FIERCEPHARMA
At FDA request, Pfizer to examine a longer course of Paxlovid
22 Aug 2022 //
FIERCEPHARMA
FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound
19 Aug 2022 //
REUTERS
Dr. B Raises $8 Million for New Telehealth Service
16 Aug 2022 //
BUSINESSWIRE
Pfizer quarterly sales surge to record high, driven by Paxlovid
28 Jul 2022 //
CNBC
Pfizer poised to maintain pandemic sales dominance
28 Jul 2022 //
FIERCEPHARMA
Zenara pharma to launch generic Paxlovid soon
27 Jul 2022 //
ECONOMIC TIMES
Paxlovid sales are due to slip from 2023 on, GlobalData predicts
23 Jul 2022 //
FIERCEPHARMA
